Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Herrington WG. et al, (2020), Clin Kidney J, 13

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.

Zhu P. et al, (2020), Int J Obes (Lond)

Maternal and perinatal Health Research Collaboration, India (MaatHRI): methodology for establishing a hospital-based research platform in a low and middle income country setting

NAIR M. et al, (2020), F1000Research

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.

Mafham MM. et al, (2020), Lancet

Questioning statin therapy for older patients - Authors' reply.

Fulcher J. et al, (2020), Lancet, 395, 1832 - 1833

Impact of the COVID-19 pandemic on admission rates for, and management of, acute coronary syndromes in England.

CASADEI B. et al, (2020), The Lancet

Clinical trial recommendations for potential Alport syndrome therapies.

Weinstock BA. et al, (2020), Kidney International, 97, 1109 - 1116

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Cosentino F. et al, (2020), Revista Espanola de Cardiologia, 73, 404.e1 - 404.e59

2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC).

Brugada J. et al, (2020), Eur Heart J, 41, 655 - 720

Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

Task Force Members None. et al, (2020), Atherosclerosis, 294, 80 - 82

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Konstantinides SV. et al, (2020), Eur Heart J, 41, 543 - 603

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Knuuti J. et al, (2020), Eur Heart J, 41, 407 - 477

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Cosentino F. et al, (2020), Eur Heart J, 41, 255 - 323

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Mach F. et al, (2020), Eur Heart J, 41, 111 - 188

Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205].

Authors/Task Force Members None. et al, (2020), Atherosclerosis, 292, 160 - 162

Ghidul societăţii europene de cardiologie (Esc)/ societăţii europene de ateroscleroză (eas) pentru diagnosticul şi tratamentul dislipidemiilor 2019: modificările lipidice în vederea reducerii riscului cardiovascular

Mach F. et al, (2020), Revista Romana de Cardiologie, 30, 263 - 357

Maternal and perinatal Health Research Collaboration, India (MaatHRI): methodology for establishing a hospital-based research platform in a low and middle income country setting.

Nair M. et al, (2020), F1000Res, 9

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.

Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol

Investigating modifications to participant information materials to improve recruitment into a large randomized trial.

HPS2-THRIVE Collaborative Group None. et al, (2019), Trials, 20

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

Authors/Task Force Members None. et al, (2019), Atherosclerosis, 290, 140 - 205

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?